Partners in Prevention: New Approaches to BV Treatment
This webinar is on-demand and can be viewed at your convenience.
Bacterial vaginosis remains the most common vaginal infection among reproductive-age women. NIH research links recurrence to major clinical and economic burdens for health systems. Yet outdated diagnostics and incomplete treatment continue to fuel high recurrence and partner transmission.
In this on-demand session, Anna Maya Powell, MD, assistant professor of gynecology and obstetrics at Johns Hopkins University School of Medicine, explains how co-infections complicate diagnosis and why conventional treatments often fall short.
You'll hear how advanced molecular testing is enabling more effective care pathways — helping clinicians finally get ahead of recurrent BV.
Watch to explore:
The impact of partner transmission on recurrence and treatment success
How molecular diagnostics are reshaping BV management and what clinicians should expect next
Strategies for reducing misdiagnosis and improving patient outcomes
Presenter:
Anna Maya Powell, MD, MSCR
Assistant Professor of Gynecology and Obstetrics, Johns Hopkins University, School of Medicine
